ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
21 May 2019 09:07

Celltrion H Block Deals Priced at Floor: More Short Entry Points Should Be On the Way

This block deal was another nice exit point for Celltrion H short sellers to wrap up short position. Just, 6.5M offering was simply massive, and...

Logo
584 Views
Share
20 May 2019 21:29

One Equity Partners Plans to Sell 4.5% Stake of Celltrion Healthcare

It was announced after market close today that One Equity Partners plans to sell 6.5 million shares (4.5% of shares outstanding) of Celltrion...

Logo
556 Views
Share
13 May 2019 17:58

Smartkarma’s Week that Was in JP/​​​​​​​KR: Chiyoda, SoftBank, Nexon and CJ Olive Networks

We have covered two weeks of insights in this week’s report as we did not publish the weekly during the first week of May as Japan was enjoying an...

Share
bullishCelltrion Inc
30 Apr 2019 11:55

Celltrion Cycle Low Synergies

Celltrion Inc (068270 KS) has some clear signals that a macro bottom is taking shape as retracement and price synergy suggest the recent low is of...

Share
bearishCelltrion Inc
28 Feb 2019 11:30

Biosimilar Battlefield: Unpacking Celltrion

Both Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) have reported preliminary 2018 results with some MD&A. As suspected, Q4's...

Share
x